Triton Algae Innovations

Triton Algae Innovations

Biotechnology company developing proteins from algae for animal and human health and address world's food shortages

Triton Algae Innovation is a California based biotechnology company developing and cultivating green algae as a sustainable and affordable source of alternative protein to help meet increasing domestic and global demand. The company cultivates green algae which are Generally Recognized As Safe (GRAS) which provides a platform for the production of nutritional ingredients and colostrum protein which occur naturally in breast milk of all mammals. The company aims to become a provider to supply algae as an ingredient to food manufacturers.


Triton cultivates safe, natural, and wild-type algae, Chlamydomonas reinhardtii (c. reinhardtii), found in freshwater and soil all over the world. The algae are then dried and converted into a powdered form which retains protein, iron, amino acids, calcium, Vitamin A, and Omega 3, 6, and 9 fatty acids. The company uses advanced proprietary synthetic biological tools for the safe expression of milk and meat protein without any genetic engineering. The company has set up a large scale production line to fulfill the growing trend of the sustainable food industry.

Triton also developed Osteopontin (OPN) with c reinhardtii with collaboration with Dr. Bo Lonnerdal, a milk protein researcher at U.C. Davis. The protein is one of many colostrum protein.which is found naturally in every mammal's mother’s milk.This protein allows infant formula manufacturers to make their products closer to the nutritional makeup of human breastmilk.

Triton has identified strains of the algae which are capable of growing in green and yellow colors after the fermentation process. The powdered form is intended to be used as an ingredient for foods and beverages like nutritional bars, infant formula, yogurts, juices and energy drinks.


Nick Hofmeister, Beth Rasala, Daniel Sachs, Jason Pyle, Miller Tran, Stephen Mayfield, and William Julien founded the company in 2013.


June 15, 2015

Triton Algae Innovations raises a $5,000,000 venture round.

September 4, 2013

Triton Algae Innovations raises a $5,000,000 series A round from Heliae.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine



Amanda Longo

Research Assistant

Bill Baum

Chief Business Officer

Brock Adams

Research Associate

David Schroeder

Director of Corporate and Regulatory Affairs

Dr. Jon Hansen

Chief Engineering Officer

Dr. Miller Tran

Associate Director of Research and Development

Dr. Xun Wang

President and Chief Executive Officer

John Deaton

Research Associate

Michael Mayfield

Research Associate

Nick Hofmeister


Oscar Gonzalez

Senior Research Associate

Further reading


Documentaries, videos and podcasts


Turning green algae into colostrum-like protein for infants - Triton Algae Innovations

May 10, 2018




Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.